Recombinant CD23 (Lumiliximab Biosimilar) antibody

Catalog No. ABIN7597802

The Chimeric Chimeric anti-CD23 (Lumiliximab Biosimilar) antibody (ABIN7597802) specifically detects CD23 (Lumiliximab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant CD23 (Lumiliximab Biosimilar) antibody (ABIN7597802)

Target: CD23 (Lumiliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Lumiliximab Biosimilar Antibody

Specificity: Lymphocyte IgE receptor, C-type lectin domain family 4 member J, Low affinity immunoglobulin epsilon Fc receptor, CD23A, BLAST-2, Immunoglobulin E-binding factor, IGEBF, CD23, Fc-epsilon-RII, CLEC4J, FCE2, FCER2

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.66 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: CD23 (Lumiliximab Biosimilar)

Alternative Name: Lumiliximab Biosimilar

Target Type: Biosimilar

Background: Lymphocyte IgE receptor, C-type lectin domain family 4 member J, Low affinity immunoglobulin epsilon Fc receptor, CD23A, BLAST-2, Immunoglobulin E-binding factor, IGEBF, CD23, Fc-epsilon-RII, CLEC4J, FCE2, FCER2

UniProt: P06734

CAS-No: 357613-86-6